TRHC’s Dr. Jenny Bingham Awarded 2019 Technology Innovator of the Year

MOORESTOWN, N.J., November 19, 2019 — Tabula Rasa HealthCare® (“TRHC”) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, congratulates Dr. Jenny Bingham, PharmD, BCACP, TRHC Director of Ambulatory Care Residency Programs & Research, for being named Next-Generation Pharmacist’s 2019 Technology Innovator of the Year, an award that recognizes pharmacists who successfully leverage pharmacy technology tools to advance patient care standards, business profitability and employee productivity. The national awards program, sponsored by Parata Systems and Pharmacy Times, honors leading pharmacists and industry professionals who define the future of pharmacy. Dr. Bingham was recognized as one of 10 awardees selected from over 600 international nominations at the 10th annual awards gala held Friday, October 25th, at the Hotel del Coronado in San Diego.

Dr. Bingham, a leader in telehealth pharmacy solutions, facilitates TRHC’s award-winning research in the areas of medication safety, novel rural telehealth pharmacy programs, and healthcare outcomes associated with advanced healthcare technology developed by TRHC. In her role, Dr. Bingham also oversees the collaboration between TRHC and several of the top national colleges of pharmacy, including the University of Arizona College of Pharmacy’s Center for Health Outcomes & Pharmacoeconomic Research (HOPE Center) and Ohio State University’s Institute of Therapeutic Innovations and Outcomes.

“Our goal in executing innovative medication safety research is to optimize the delivery of patient care while maximizing program outcomes for our trusted healthcare partners,” says Dr. Bingham. “I am honored to have received the 2019 Technology Innovator of the Year award and thank my fellow dedicated colleagues who continue to advocate for the role of telehealth pharmacists in the patient care continuum.”

“TRHC cannot be prouder of Dr. Jenny Bingham, she is most deserving of this honor,” said TRHC Chairman and CEO Calvin H. Knowlton, PhD. “Dr. Bingham has dedicated her career towards enhancing the quality of health care for her patients. She is leading the charge in advancing the role of pharmacists in telehealth and pharmacist-led interventions. In addition to her research, Dr. Bingham provides multiple best practice webinars highlighting various methods in which pharmacists can integrate these innovative interprofessional models into their clinical programs. She is passionate about her patients and discovering new ways to improve medication safety and health outcomes.”

Dr. Bingham’s technology-driven initiatives are in direct alignment with TRHC’s commitment to institutional innovation and development, as evident in the organization’s 2019 launch of its Scientific Precision Pharmacotherapy Research and Development Institute. The TRHC institute, led by Jacques Turgeon, BPharm, PhD, TRHC’s Chief Scientific Officer, focuses on enhancing the organization’s clinical decision support tools through research using pharmacokinetic and pharmacodynamic modeling to optimize and develop new healthcare solutions.

For more information on TRHC’s innovative research practices, please visit trhc.com. Published work can be viewed directly by visiting TRHC’s online repository.

About Tabula Rasa Healthcare
Tabula Rasa HealthCare (NASDAQ:TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs, and manage risk. Medication risk management is TRHC’s lead offering, and its cloud-based software applications provide solutions for a range of payers, providers, and other healthcare organizations. For more information, visit TRHC.com.

About Pharmacy Times®
Pharmacy Times® is the industry-leading pharmacy resource, providing practical clinical and professional information pharmacists can use in their everyday practices when counseling patients and interacting with other health care providers. Each issue and the website contain articles and features covering industry trends, medication errors, drug interactions, patient education, disease state management, patient counseling, product news, pharmacy law and more. Additionally, Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Pharmacy Times® is a brand of MJH Life Sciences™, the largest privately held, independent, full-service medical media company in the U.S. dedicated to delivering trusted health care news across multiple channels.

About Parata Systems, LLC
Parata provides pharmacy technology solutions to reduce costs, improve health outcomes, and enhance the patient experience by offering the most comprehensive pharmacy automation portfolio with medication adherence packaging, high-speed robotic dispensing technologies, and pharmacy workflow solutions. Discover how pharmacies across all practice settings use our solutions to stay out in front at parata.com.

Forward-Looking Statements
This press release includes forward-looking statements that we believe to be reasonable as of today’s date, including statements regarding Medication Risk Mitigation technology. Such statements are identified by use of the words “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “should,” and similar expressions. These forward-looking statements are based on management’s expectations and assumptions as of the date of this press release. Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially include: the need to innovate and provide useful products and services; risks related to changing healthcare and other applicable regulations; increasing consolidation in the healthcare industry; managing our growth effectively; our ability to adequately protect our intellectual property; and the other risk factors set forth from time to time in our filings with the SEC, including those factors discussed under the caption “Risk Factors” in our most recent annual report on Form 10-K, filed with the SEC on March 1, 2019, and in subsequent reports filed with or furnished to the SEC, copies of which are available free of charge within the Investor Relations section of the TRHC website http://ir.trhc.com or upon request from our Investor Relations Department. Any forward-looking statement speaks only as of the date on which it was made. TRHC assumes no obligation and does not intend to update these forward-looking statements, except as required by law, to reflect events or circumstances occurring after today’s date.

Contact:
Media Relations
Dianne Semingson
dsemingson@TRHC.com
T: 215-870-0829

Investors
Bob East or Asher Dewhurst
Westwicke Partners
tabularasa@westwicke.com
T: (443) 213-0500

 

TRHC’s Dr. Jenny Bingham Awarded 2019 Technology Innovator of the Year